Amplius Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Amplius Wealth Advisors's PFE Position: Q3 2026 in Review
Amplius Wealth Advisors reduced its Pfizer (PFE) stake by 34% in Q3 2026, selling an estimated $129K and leaving 9,393 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #182.
Amplius Wealth Advisors first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.94M in Q4 2021. 881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Amplius Wealth Advisors held 9,393 shares of Pfizer worth $268K as of Q3 2026.
- Amplius Wealth Advisors sold 4,858 Pfizer shares in Q3 2026, an estimated $129K.
- Pfizer made up 0.02% of Amplius Wealth Advisors's portfolio in Q3 2026, its #182 holding.
- Amplius Wealth Advisors first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- Amplius Wealth Advisors's Pfizer position peaked at $1.94M in Q4 2021.
- 881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Amplius Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.